Major pharmaceutical companies, including Eli Lilly, Johnson & Johnson, and AbbVie, are significant holdings in various health care ETFs.
5 reports, 2 independent
Updated Jul 18
Gone quiet
- Reports
- 5
- Developments
- 4
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Major pharmaceutical companies, including Eli Lilly, Johnson & Johnson, and AbbVie, are significant holdings in various health care ETFs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- AbbVie, Johnson & Johnson, and Eli Lilly are noted as top holdings in specific healthcare ETFs.Sub-event
- The Vanguard Health Care ETF holds major positions in Eli Lilly and Company and Johnson & Johnson.Sub-event
Multiple major pharma/biotech firms, including J&J, AbbVie, and Amgen, are top holdings in various healthcare ETFs.1 source
ETFs are tracking major pharmaceutical businesses, including Eli Lilly, J&J, and AbbVie.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
AbbVie
pharmaceutical company
Related events
- Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital.
- Reports on the top holdings of various healthcare and biotech ETFs, listing major pharmaceutical companies like Eli Lilly, Amgen, and Johnson & Johnson.
- Financial results and stock performance comparisons among AbbVie, Johnson & Johnson, Eli Lilly, and Merck.
- Syndax Pharmaceuticals and AbbVie are competing in the healthcare and biopharma sector.
- AbbVie, Abbott Laboratories, and Johnson & Johnson were recommended as dividend stocks for retirees, operating in the healthcare sector.